Evidence map›Paper›PMID 39794863›Full record

ReviewJournal of translational medicine2025

Development and validation of a novel coronary artery disease risk prediction model.

Zu-Fei Wu, Si-Xiao Tao, Wen-Tao Su, Shi Chen, Bai-Da Xu, Gang-Jun Zong, Gang-Yong Wu

Abstract readValidation StudyReview
In one paragraph

Review in Journal of translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zu-Fei Wu *Department of Cardiology, Xuancheng People's Hospital, Xuanchen, Anhui, 242000, People's Republic of China.
Si-Xiao Tao *Department of Cardiology, Xuancheng People's Hospital, Xuanchen, Anhui, 242000, People's Republic of China.
Wen-Tao Su *Department of Cardiology, The 904th Hospital of the PLA Joint Logistics Support Force, Wuxi, Jiangsu, 214044, People's Republic of China.
Shi ChenDepartment of Cardiology, Wuxi No.5 People's Hospital, Wuxi, Jiangsu, 214044, People's Republic of China.
Bai-Da XuDepartment of Cardiology, The 904th Hospital of the PLA Joint Logistics Support Force, Wuxi, Jiangsu, 214044, People's Republic of China.
Gang-Jun ZongDepartment of Cardiology, The 904th Hospital of the PLA Joint Logistics Support Force, Wuxi, Jiangsu, 214044, People's Republic of China.
Gang-Yong WuDepartment of Cardiology, The 904th Hospital of the PLA Joint Logistics Support Force, Wuxi, Jiangsu, 214044, People's Republic of China. wuwangyi520@sina.com.ORCID 0000-0003-3310-6488

Funding

Major Basic Research Project of the Natural Science Foundation of the Jiangsu Higher Education Institutions BK20201139Wuxi Science and Technology Association N20202035
6 · The paper itself

Abstract

objectiveThis study aims to develop a novel risk assessment tool for coronary artery disease (CAD) based on data of patients with chest pain in outpatient and emergency department, thereby facilitating the effective identification and management of high-risk patients.

methodsA retrospective analysis was conducted on patients hospitalized for chest pain. Patients were divided into a control group and a CAD group based on angiographic results. Logistic regression was used to identify factors associated with CAD, and R-Studio was utilized to construct the CAD risk prediction model.

resultsMultivariate logistic regression analysis indicated that age, gender, diabetes, ECG (electrocardiogram) ST-T changes, neutrophils (NE), coronary artery calcification (CAC), and typical chest pain were independent factors associated with CAD. Based on the results of multifactorial logistic analysis, the CAD risk prediction model built with R-Studio had a highest C-index of 0.909, and a validation cohort C-index of 0.897, demonstrating excellent predictive ability. Decision Curve Analysis showed that the model significantly outperformed others in terms of clinical net benefit.

conclusionThe present study successfully developed a CAD risk assessment model based on Chinese population. This novel model could be used to assess CAD risk in patients with chest pain, optimize clinical decision making, and improve patient outcomes, regardless of whether it is applied in large hospitals or resource-limited Community Healthcare Center.

Indexed as

Coronary Artery DiseaseAgedFemaleHumansLogistic ModelsMaleMiddle AgedMultivariate AnalysisReproducibility of ResultsRetrospective StudiesRisk AssessmentRisk FactorsROC CurveCoronary artery diseaseInflammationRisk assessment

Identifiers

PMID39794863
PMCPMC11720542

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.